Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patientsL Del Mastro, M Venturini, C Viscoli, et al.
Haematologica|March 20, 2001
Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphomaG Santini, S Nati, M Spriano, et al.
Haematologica|February 22, 2000
VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study GroupG Santini, P Coser, A M Congiu, et al.
British Journal of Cancer|October 17, 2013
CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2D Bedognetti, T L Spivey, Y Zhao, et al.
Leukemia & Lymphoma|May 7, 1998
Mobilization/transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvementG Santini, A M Congiu, S Nati, et al.
Leukemia|June 1, 1996
Mobilization/transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvementG Santini, A M Congiu, S Nati, et al.
Leukemia & Lymphoma|April 30, 1999
High-dose cyclophosphamide followed by autografting can improve the outcome of relapsed or resistant non-Hodgkin's lymphomas with involved or hypoplastic bone marrowG Santini, C De Souza, A M Congiu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 15, 2005
Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSGA Olivieri, G Santini, C Patti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study GroupG Santini, L Salvagno, P Leoni, et al.
Pageof 8